Fumie Fujisawa

Moriyama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.

Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: February 12, 2026

Correction: Real‑world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first‑ or second‑line treatment for hormone receptor-positive, HER2‑negative advanced or metastatic breast cancer.

Correction: Real‑world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first‑ or second‑line treatment for hormone receptor-positive, HER2‑negative advanced or metastatic breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: June 23, 2025

Current Status and Issue of Emesis and Vomiting Caused by Trastuzumab Deruxtecan

Current Status and Issue of Emesis and Vomiting Caused by Trastuzumab Deruxtecan

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 17, 2025

Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.

Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: January 28, 2025

Radiation-Induced Angiosarcoma Arising in Bilateral Breast: A Case Report.

Radiation-Induced Angiosarcoma Arising in Bilateral Breast: A Case Report.

Journal: Cureus

Published: September 06, 2024

Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer.

Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer.

Journal: BMC cancer

Published: February 10, 2024

Real-world assessment of comprehensive genome profiling impact on clinical outcomes: A single-institution study in Japan.

Real-world assessment of comprehensive genome profiling impact on clinical outcomes: A single-institution study in Japan.

Journal: Cancer medicine

Published: February 04, 2024

Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer.

Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: June 29, 2023

Early detection of brain metastases and appropriate local therapy followed by systemic chemotherapy may improve the prognosis of gastric cancer.

Early detection of brain metastases and appropriate local therapy followed by systemic chemotherapy may improve the prognosis of gastric cancer.

Journal: Scientific reports

Published: June 12, 2023

Fifteen-year survival and conditional survival of women with breast cancer in Osaka, Japan: A population-based study.

Fifteen-year survival and conditional survival of women with breast cancer in Osaka, Japan: A population-based study.

Journal: Cancer medicine

Published: January 11, 2023

Progression of duodenal neoplasia to advanced adenoma in patients with familial adenomatous polyposis.

Progression of duodenal neoplasia to advanced adenoma in patients with familial adenomatous polyposis.

Journal: Hereditary cancer in clinical practice

Published: December 28, 2022

Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice.

Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice.

Journal: Cancers

Published: December 26, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026